Factors and preventive strategies for perioperative euglycemic diabetic ketoacidosis in patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors: a retrospective study
Abstract Background Invasive treatment and the associated stress are known risk factors for sodium-glucose cotransporter 2 inhibitor (SGLT2i)-induced euglycemic diabetic ketoacidosis (euDKA) development. It is recommended that SGLT2is is discontinued at least 3 days prior to a scheduled surgery. How...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-08-01
|
| Colecção: | Journal of Pharmaceutical Health Care and Sciences |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s40780-025-00487-6 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|